EUVIMEDEUVIMED entdecken
Crossref

Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC)

Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 16-16

DOI: 10.1111/ajco.70231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC). Asia-Pacific Journal of Clinical Oncology, 22(S6), 16-16. https://doi.org/10.1111/ajco.70231

Vancouver

Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC). Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):16-16. doi:10.1111/ajco.70231

BibTeX
@article{euvimed2026,
  title = {Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC)},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {S6},
  pages = {16--16},
  doi = {10.1111/ajco.70231}
}
Kostenlos starten →